What are the diagnostic criteria for post-streptococcal glomerulonephritis (PSGN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Post-Streptococcal Glomerulonephritis (PSGN)

The diagnosis of post-streptococcal glomerulonephritis requires evidence of recent streptococcal infection (pharyngitis 1-2 weeks prior or impetigo 4-6 weeks prior), clinical features of glomerulonephritis, and laboratory findings showing low complement levels and elevated streptococcal antibodies. 1

Clinical Presentation

  • Evidence of recent streptococcal infection: pharyngitis (1-2 weeks prior) or impetigo (4-6 weeks prior) 2, 1
  • Acute onset of nephritic syndrome characterized by:
    • Hematuria (microscopic or macroscopic) with red blood cell casts 2, 3
    • Proteinuria (variable severity, can range from mild to nephrotic range) 3, 4
    • Hypertension (present in up to 95% of cases in acute phase) 5
    • Edema (due to fluid retention) 3
    • Decreased urine output 3
  • Note: Some cases may present with minimal urinary abnormalities, so normal urinalysis does not rule out PSGN 6

Laboratory Criteria

  • Urinalysis:
    • Glomerular hematuria with red blood cell casts 2
    • Proteinuria (measure albumin-creatinine ratio or protein-creatinine ratio) 2
  • Serological evidence of streptococcal infection:
    • Elevated anti-streptolysin O (ASO) titers 2, 7
    • Elevated anti-DNAse B antibodies 2
    • Elevated anti-hyaluronidase antibodies 2
  • Complement studies:
    • Low C3 complement levels (hallmark finding) 2, 1, 7
    • C4 typically normal (helps differentiate from other forms of glomerulonephritis) 2
    • Persistently low C3 beyond 12 weeks warrants kidney biopsy to exclude C3 glomerulonephritis 2
  • Kidney function tests:
    • Elevated serum creatinine and decreased eGFR (in severe cases) 2, 3

Microbiological Criteria

  • Culture of throat or skin lesions if active infection is present 2
  • Positive cultures may not be obtained if presentation occurs weeks after the initial infection 2, 1

Histopathological Criteria (if biopsy performed)

  • Diffuse proliferative glomerulonephritis 3
  • Neutrophil infiltration 7
  • Subepithelial "humps" on electron microscopy (pathognomonic) 7
  • Positive immunofluorescence for C3 and IgG 7
  • Presence of nephritis-associated plasmin receptor (NAPlr) in some cases 7
  • Crescents may be present in severe cases (poor prognostic sign) 3, 4

Differential Diagnosis Exclusion

  • Rule out other causes of nephritis:
    • Antinuclear antibody (ANA) negative 2
    • Anti-neutrophil cytoplasmic antibody (ANCA) negative 2
    • Anti-glomerular basement membrane (GBM) antibody negative 2
    • Normal rheumatoid factor and cryoglobulins 2

Special Considerations

  • Kidney biopsy is indicated when:
    • Diagnosis is uncertain 2
    • Atypical presentation 2
    • Persistently low C3 beyond 12 weeks 2
    • Rapidly progressive course 4
    • Nephrotic-range proteinuria 4
  • Histological diversity exists - some cases may present as membranoproliferative glomerulonephritis (MPGN) 7

Prognostic Indicators

  • Poor prognostic factors include:
    • Crescent formation on biopsy 3
    • Renal insufficiency at presentation 3
    • Hypoalbuminemia 3
    • Elevated C-reactive protein 3
    • Persistent hypertension during disease evolution 5

Remember that while PSGN is typically self-limiting with supportive care, patients with severe presentations (crescentic glomerulonephritis, nephrotic syndrome) may require more aggressive management and closer monitoring 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.